Remarkably, imaging data and postmortem analyses showed very limited tau pathology, low hippocampal atrophy and normal glucose metabolism despite extremely high levels of amyloid plaques, suggesting that apoE Christchurch may directly prevent tau pathology spreading even in the presence of a high amyloid load [32, 192]. The gene discussed is APOE; the disease is amyloidosis.